Skip to main content
Log in

Antidepressants in suicide: differences in fatality and drug utilisation

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

All forensic autopsy cases in southern Sweden in 1986–89 in which antidepressant drugs were found in the blood were assessed and the findings related to the sales of antidepressants as expressed as defined daily doses per 1,000 inhabitants per day. There was a total of 272 antidepressant-positive cases, which were divided in three groups: 1. suicide or possible suicide caused by antidepressant drugs, 2. suicide or possible suicide caused by other means (including other drugs and other toxic agents), and 3. other deaths.

Amitriptyline was the agent most commonly involved in suicide or possible suicide caused by antidepressants, and it was also the most commonly sold antidepressant. When corrected for sales, trimipramine was most frequently involved as the causal agent.

Conversely, despite frequent sales, lofepramine appeared only rarely to be involved. This may be related to lower toxicity of lofepramine, reduced lofepramine absorption at overdose and/or to differences in the administration of various antidepressant drugs to patients with differing degrees of risk of suicide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stern H, Konetschny J, Herrmann L, Säwe U, Belz GG (1985) Cardiovascular effects of single doses of the antidepressants amitriptyline and lofepramine in healthy subjects. Pharmacopsychiatry 78: 272–277

    Google Scholar 

  2. Leonhard BE (1987) A comparison of the pharmacological properties of the novel tricyclic antidepressant lofepramine with its major metabolite, desipramine: a review. Int Clin Psychopharmacol 2: 281–297

    Google Scholar 

  3. Reid F, Henry JA (1990) Lofepramine overdosage. Pharmacopsychiatry 23: 23–27

    Google Scholar 

  4. Wessling A, Boëthius G (1990) Measurements of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology. Eur J Clin Pharmacol 39: 207–210

    Google Scholar 

  5. Wessling A, Bergman U, Westerholm N (1991) On the differences in psychotropic drug use between the three major urban areas in Sweden. Eur J Clin Pharmacol 40: 495–500

    Google Scholar 

  6. Barraclough BM (1974) Are there safer hypnotics than barbiturates? Lancet I: 57–58

    Google Scholar 

  7. King LA, Moffat AC (1983) A possible index of fatal drug toxicity in humans. Med Sci Law 23: 193

    Google Scholar 

  8. Henry JA (1989) A fatal toxicity index for antidepressant poisoning. Acta Psychiatr Scand 80 [Suppl 354]: 37–45

    Google Scholar 

  9. Cassidy S, Henry J (1987) Fatal toxicity of antidepressant drugs in overdose. Br Med J 295: 1021–1024

    Google Scholar 

  10. Beaumont G (1989) Suicide and antidepressant overdosage in general practice. Br J Psychiatry 155 [Suppl 6]: 27–31

    Google Scholar 

  11. Erikson E, Rohte O (1970) Chemistry and pharmacology of a new potential antidepressant. Arzneimittelforschung (Drug Research) 20: 1561–1569

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malmvik, J., Löwenhielm, C.G.P. & Melander, A. Antidepressants in suicide: differences in fatality and drug utilisation. Eur J Clin Pharmacol 46, 291–294 (1994). https://doi.org/10.1007/BF00194393

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00194393

Key words

Navigation